Clinical Report: Assessment of a Non-Invasive, Cuffless Device for Continuous Blood Pressure Monitoring in ICU Patients
Overview
This study evaluates the accuracy and stability of a new cuffless blood pressure monitoring device based on pulse wave transit time (PWTT) in ICU patients.
Background
Continuous blood pressure monitoring is critical in the management of ICU patients, as it informs clinical decisions regarding fluid resuscitation and vasopressor therapy. Traditional invasive methods, while accurate, carry risks such as infection and complications from catheter placement. Non-invasive methods, although safer, often lack the ability to provide continuous measurements, which can delay the detection of hypotensive events.
Data Highlights
This study systematically validated a wrist-worn continuous non-invasive blood pressure (CNIBP) monitoring device against invasive blood pressure (IBP) measurements, demonstrating its potential for real-time hemodynamic management in critically ill patients.
Key Findings
The mWear device provides CNIBP readings at a minimum interval of 3 seconds.
Measurements were compared with IBP values according to ISO 81060-3:2022 standards.
The device requires recalibration every 24 hours to maintain accuracy.
This study is the first to validate the device's long-term stability and dynamic tracking capability in an ICU setting.
Clinical Implications
The introduction of the mWear device may offer a safer alternative for continuous blood pressure monitoring in patients where invasive methods are contraindicated. Its ability to provide real-time data could improve clinical decision-making in critical care settings.
Conclusion
The validation of the mWear cuffless device represents a significant advancement in non-invasive blood pressure monitoring technology, potentially enhancing patient care in the ICU.
Metabolomics analysis identified higher uric acid levels in patients with lipedema and lymphedema, although associations weakened following adjustment for renal insufficiency.
